Ovarian adenosarcoma with elevated CA 125 antigen serum. A case report and literature review;Adenosarcoma de ovario asociado con elevación del antígeno sérico Ca-125. Informe de caso y revisión de literatura

Cirugia y Cirujanos

Volumn 76, Issue 1, 2008, Pages 71-75

  Recinos Money, Edgar ^a   Escobar Alfaro, Gustavo ^b   Contreras, Jorge ^a   Zepeda Castilla, Ernesto ^b   Parra Torres, Carlos ^b   Di Castro, Paolo ^c  

^a Hospital Santa Teresa de Las Lomas   (Mexico)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^c Hospital Santa Teresa de Las Lomas   (Mexico)

Author keywords

Adenosarcoma; CA125; Ovary

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CA 125 ANTIGEN; MEDROXYPROGESTERONE; TUMOR MARKER;

ADENOSARCOMA; ADJUVANT CHEMOTHERAPY; ADULT; BLOOD; CASE REPORT; FEMALE; HUMAN; HYSTERECTOMY; INCIDENTAL FINDING; LYMPHADENECTOMY; MUELLERIAN DUCT; OMENTUM; OVARIECTOMY; OVARY TUMOR; PATHOLOGY; PRENATAL DEVELOPMENT; PROGNOSIS; REMISSION; REVIEW;

ADENOSARCOMA; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; CA-125 ANTIGEN; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; HYSTERECTOMY; INCIDENTAL FINDINGS; LYMPH NODE EXCISION; MEDROXYPROGESTERONE; MULLERIAN DUCTS; OMENTUM; OVARIAN NEOPLASMS; OVARIECTOMY; PROGNOSIS; REMISSION INDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 70450067456     PISSN: 00097411     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Clement PB, Scully RE. Müllerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol 1990;21:363-381.
2. Clement PB, Scully RE. Müllerian adenosarcoma of the uterus: a clinicopathologic analysis of ten cases of a distinctive type of Müllerian mixed tumor. Cancer 1974;34:1138-1149.
3. Eichhorn JH, Young RH, Clement PB, Scully RE. Mesodermal (Müllerian) adenosarcoma of the ovary: a clinicopathologic analysis of 40 cases and a review of the literature. Am J Surg Pathol 2002;26:1243-1258.
4. Dellers EA, Valente PT, Edmonds PR, Balsara G. Extrauterine mixed mesodermal tumors: an immunohistochemical study. Arch Pathol Lab Med 1981;115:918-920.
5. Kao GF, Norris HJ. Benign and low grade variants of mixed mesodermal tumor (adenosarcoma) of the ovary and adnexal region. Cancer 1978;42:1314-1324.
6. Valdez VA, Planas AT, Lopez VF, Goldberg M, Herrera NE. Adenosarcoma of the uterus and ovary: a clinicopathologic study of two cases. Cancer 1979;43:1439-1447.
7. Inoue M, Fukuda H, Tanizawa O. Adenosarcoma originating from sites other than uterine endometrium. Int J Gynecol Obstet 1995;48:299-306.
8. Fukunaga M, Nomura K, Endo Y, Ushigome S, Aizawa S. Ovarian adenosarcoma. Histopathology 1997;30:283-287.
9. Hirakawa E, Kobayashi S, Miki H, et al. Ascitic fluid cytology in adenosarcoma of the ovary: a case report. Diagn Cytol 2001;24:343-346.
10. Clemet PB, Scully RE. Extrauterine mesodermal (Müllerian) adenosarcoma. A clinicopathologic analysis of five cases. Am J Clin Pathol 1978;69:276-283.
11. Gollard R, Kosty M, Bordin G, Wax A, Lacey C. Two unusual presentations of Müllerian adenosarcoma: case report, literature review, and treatment considerations. Gynecol Oncol 1995;59:412-422.
12. Kwok A, Lam A, Ford R. Deeply infiltrating endometriosis: implications, diagnosis and management. Obstet Gynecol Surv 2001;58:168-177.
13. Millares C, Orea M, España P, et al. Cancer antigen 125 associated with multiple benign and malignant pathologies. Ann Surg Oncol 2003;10:150-154.
14. Parker RL, Dadmanesh F, Young RH, Clement PB. Polypoid endometriosis: a clinicopathologic analysis of 24 cases and a review of the literature. Am J Surg Pathol 2004;28:285-297.
15. Östör AG, Nirenberg A, Ashdown ML, Murphy DJ. Extragenital adenosarcoma arising in the pouch of Douglas. Gynecol Oncol 1994;53:373-375.
16. Hines BJ, Porges RF, Mittal K, Muggia FM, Curtin JP. Use of medroxyprogesterone acetate in the treatment of Müllerian adenosarcoma: a case report. Gynecol Oncol 2002;85:192-195.
17. De Jonge MJ, Van Dam PA, Van Marck E, Prove A, Van Oosterom AT. Primary extrauterine Müllerian adenosarcoma of the peritoneum. Gynecol Oncol 1995;57:126-130.
18. World Health Organization Classification of Tumours. In: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Tavassoli FA, Devilee P, eds., Lyon: IARC Press;2003. pp. 114-115.
19. Hirschfield L, Kahn LB, Chen S, Winkler B, Rosenberg S. Müllerian adenosarcoma with ovary sex cord-like differentiation: a light- and electronmicroscopic study. Cancer 1986;57:1197-1200.
20. Kerner H, Lichtig C, Beck D. Extrauterine Müllerian adenosarcoma of the mesothelium: a clinicopathologic and electron microscopic study. Obstet Gynecol 1989;73:510-513.
21. Benda JA, Veronezi-Gurwell A, Wilcox M, Buller R. An unusual extrauterine variant of adenosarcoma with multiple recurrences over 16 years. Gynecol Oncol 1994;53:131-137.
22. Russell P, Slavutin L, Laverty CR, Cooper-Booth J. Extrauterine mesodermal (Müllerian) adenosarcoma. A case report. Pathology 1979;11:557-560.
23. Scully RE, Young RH, Clement PB. Endometrioid tumors. In: Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. Atlas of Tumor Pathology, Third series. Fascicle 23. Washington: AFIP;1998. pp. 107-140.
24. Prat J. Pathology of the Ovary. Philadelphia: Elsevier;2004. pp. 145-147.
25. Michener CM, Simon NL. Ovarian conservation in a woman of reproductive age with Müllerian adenosarcoma. Gynecol Oncol 2001;83:424-427.
26. Kaku T, Silverberg SG, Major FJ, Miller A, Fetter B, Brady MF. Adenosarcoma of the uterus: a gynecologic oncology group clinicopathologic study of 31 cases. Int J Gynecol Pathol 1992;11:75-88.
27. Seidman JD, Chauhan S. Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas. Int J Gynecol Pathol 2003;22:75-82.